High von Willebrand Factor Levels Increase the Risk of First Ischemic Stroke: Influence of ADAMTS13, Inflammation, and Genetic Variability

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Stroke

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000244767.39962.f7PMID 16990571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke

  2005cited by this paper
• High functional levels of thrombin‐activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke

  2005cited by this paper
• ABO locus O1 allele and risk of myocardial infarction

  2004cited by this paper
• Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.

  2004cited by this paper
• von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women

  2004cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study

  2004cited by this paper
• Plasma levels of von Willebrand factor regulate ADAMTS‐13, its major cleaving protease

  2004cited by this paper
• Airborne Occupational Exposure, ABO Phenotype and Risk of Ischaemic Heart Disease in the Copenhagen Male Study

  2002cited by this paper
• Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura.

  2001cited by this paper
• Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

  2001cited by this paper
• Platelet Glycoprotein IIIa PlA Polymorphism, Fibrinogen, and Platelet Aggregability: The Framingham Heart Study

  2001cited by this paper
• Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura*

  2001cited by this paper
• A single nucleotide polymorphism at nucleotide −1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels

  2000cited by this paper
• Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase.

  1999cited by this paper
• Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

  1999cited by this paper
• Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

  1998cited by this paper
• Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.

  1997cited by this paper
• von Willebrand Factor and Factor VIII: C in Acute Cerebrovascular Disease

  1997cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• The effect of ABO blood group on the diagnosis of von Willebrand disease.

  1987cited by this paper
• Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura.

  1982cited by this paper

• Reinventing the wheel in ischemic stroke: Novel aspects in ADAMTS13 and von Willebrand axis.

  2026cites this paper
• Targeting von Willebrand factor selectively under inflammatory conditions

  2026cites this paper
• Asthma and Stroke: Unraveling the Link Between Inflammation and Vascular Health

  2025cites this paper
• Neuroprotective and Anti-Inflammatory Activity of Undaria pinnatifida Fucoidan In Vivo—A Proteomic Investigation

  2025cites this paper
• A Panel of Blood Biomarkers for the Diagnosis of Transient Ischemic Attacks

  2025cites this paper
• Association Of ABO Blood Group with Incidence Of Ischemic stroke:An Observational Study

  2025cites this paper
• Severe ADAMTS-13 Deficiency Without Hemolysis as a Cause of Cryptogenic Stroke: A Single Center Case Series.

  2025cites this paper
• Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke

  2025cites this paper
• Prospective Study of ADAMTS13 and von Willebrand Factor’s Role in the Prediction of Outcomes in Acute Ischemic Stroke

  2025influential citation
• Fibrosis 4 Index Predicts Haemocompatibility-Related Adverse Events in Patients Using Left Ventricular Assist Devices

  2025cites this paper
• Effects of combined aerobic and resistance training with functional electrical stimulation (FES) on inflammatory, hemostatic, and lipid profile markers in men after ischemic stroke: a randomized controlled trial.

  2025cites this paper
• Immune-mediated thrombotic thrombocytopenic purpura as a model of systemic microvascular dysfunction: moving from an acute to a chronic disorder.

  2025cites this paper
• The von Willebrand factor/ADAMTS13 ratio as an indicator of venous thromboembolism risk: results from the RETROVE project

  2025cites this paper
• Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle

  2024cites this paper
• Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells

  2024cites this paper
• Von Willebrand Factor Antigen Levels Predict Poor Outcomes in Patients With Stroke and Cancer: Findings From the Multicenter, Prospective, Observational SCAN Study.

  2024cites this paper
• ISCHAEMIC STROKE, THROMBOEMBOLISM AND CLOT STRUCTURE.

  2024cites this paper
• Exploring ligands that target von Willebrand factor selectively under oxidizing conditions through docking and molecular dynamics simulations

  2024cites this paper
• von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy.

  2024cites this paper
• Exploring ligands that target von Willebrand factor selectively under oxidizing conditions through docking and molecular dynamics simulations

  2024cites this paper
• Prevalence Of Non O Blood Group In patients admitted with Ischemic stroke at Tertiary care center:A Descriptive Cross sectional Study

  2024cites this paper
• The relative risk of ischemic cerebrovascular accident in patients with Von Willebrand disease

  2023cites this paper
• Supplemental oxygen did not significantly affect two-year mortality in patients at-risk for cardiovascular complications undergoing moderate- to high-risk abdominal surgery–A follow-up analysis of a prospective randomized clinical trial

  2023cites this paper
• Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection

  2023cites this paper
• Coagulation Factor VIII Regulates von Willebrand Factor Homeostasis In Vivo.

  2023cites this paper
• REVIEWING THE DYSREGULATION OF ADAMTS13 AND VWF IN SEPSIS

  2023cites this paper
• Blood group and ischemic stroke, myocardial infarction, and peripheral vascular disease: A meta-analysis of over 145,000 cases and 2,000,000 controls.

  2023cites this paper
• The role of RhoA/ROCK pathway in the ischemic stroke-induced neuroinflammation.

  2023cites this paper
• von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts

  2022cites this paper
• A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen−deuterium exchange plus mass spectrometry

  2022cites this paper
• Changes in Plasma Levels of ADAMTS13 and von Willebrand Factor in Patients Undergoing Elective Joint Arthroplasty

  2022cites this paper
• Nanoparticle personalized biomolecular corona: implications of pre-existing conditions for immunomodulation and cancer.

  2022cites this paper
• Sex differences in thrombosis as it affects acute ischemic stroke.

  2022cites this paper
• Breast cancer cells-derived Von Willebrand Factor promotes VEGF-A-related angiogenesis through PI3K/Akt-miR-205-5p signaling pathway.

  2022cites this paper
• Constitutively active ADAMTS13: An emerging thrombolytic agent for acute ischemic stroke

  2022cites this paper
• Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer

  2022cites this paper
• Relationships Between Transcranial Doppler Velocity, Von Willebrand Factor, Factor VIII, and Hematological Parameters in Children with Sickle Cell Anemia: A Comparative Cross-Sectional Study

  2022cites this paper
• Verification of the Role of ADAMTS13 in the Cardiovascular Disease Using Two-Sample Mendelian Randomization

  2021cites this paper
• Neutrophils and Platelets: Immune Soldiers Fighting Together in Stroke Pathophysiology

  2021cites this paper
• Biomarkers in the clinical management of patients with atrial fibrillation and heart failure

  2021cites this paper
• Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke

  2021cites this paper
• Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension

  2021cites this paper
• Low ADAMTS‐13 predicts adverse outcomes in hospitalized patients with suspected heparin‐induced thrombocytopenia

  2021cites this paper
• The Manifold Cellular Functions of von Willebrand Factor

  2021cites this paper
• Radiology-Pathology Correlations of Intracranial Clots: Current Theories, Clinical Applications, and Future Directions

  2021cites this paper
• CEREBRAL AND SYSTEMIC ENDOTHELIAL DYSFUNCTION IN MIGRAINE: CURRENT KNOWLEDGE AND PERSPECTIVE

  2021cites this paper
• Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy

  2021cites this paper
• Assessment of vascular function in complete glycaemic spectrum

  2021cites this paper
• Plasma levels of von Willebrand factor in type 2 diabetes patients with and without cardiovascular diseases: A meta‐analysis

  2020cites this paper
• The von Willebrand factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice

  2020cites this paper
• Emerging mechanisms to modulate VWF release from endothelial cells.

  2020cites this paper
• Platelets as Mediators of Neuroinflammation and Thrombosis

  2020cites this paper
• Atrial Myopathy Underlying Atrial Fibrillation

  2020cites this paper
• Periodontitis y su relación con el ictus isquémico

  2020cites this paper
• Perioperative cardiovascular complications rate and activity of coagulation and fibrinolysis among patients undergoing vascular surgery for peripheral artery disease and abdominal aortic aneurysm

  2020cites this paper
• The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin

  2020cites this paper
• Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus

  2020cites this paper
• The Association Between Vascular Inflammation and Depressive Disorder. Causality, Biomarkers and Targeted Treatment

  2020cites this paper
• Consumptive Coagulopathy and Thrombosis during Severe COVID-19 Infection: Potential Involvement of VWF/ADAMTS13

  2020cites this paper
• Drug interaction and rational drug therapy in hospitalized patients reported with stroke

  2020cites this paper
• von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli

  2020cites this paper
• Prognostic value of plasma von Willebrand factor levels in major adverse cardiovascular events: a systematic review and meta-analysis

  2020cites this paper
• von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome.

  2020cites this paper
• Stroke Classification: Critical Role of Unusually Large von Willebrand Factor Multimers and Tissue Factor on Clinical Phenotypes Based on Novel “Two-Path Unifying Theory” of Hemostasis

  2020cites this paper
• Electrostatic Ste Flow-Activated V Factor to Bind P Revealed by Sin Stretching and

  2019cites this paper
• ADAMTS13: An Emerging Target in Stroke Therapy

  2019cites this paper
• Neurovascular Unit as a Source of Ischemic Stroke Biomarkers—Limitations of Experimental Studies and Perspectives for Clinical Application

  2019cites this paper
• Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians

  2019cites this paper
• Risk stratification and prognostic evaluation of endothelial cell-specific molecule1, von Willebrand factor, and a disintegrin-like and metalloprotease with thrombospondin type 1 motif for sepsis in the emergency department: An observational study.

  2019cites this paper
• Circulating Biomarkers In Migraine. New Opportunities For Precision Medicine.

  2019cites this paper
• Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors.

  2019cites this paper
• Platelets as Modulators of Cerebral Ischemia/Reperfusion Injury

  2019cites this paper
• von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke

  2019cites this paper
• No independent association found between von Willebrand factor and plaque ulceration in carotid artery atherosclerosis.

  2019cites this paper
• Electrostatic Steering Enables Flow-Activated Von Willebrand Factor to Bind Platelet Glycoprotein, Revealed by Single-Molecule Stretching and Imaging.

  2019cites this paper
• Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study.

  2019cites this paper
• Platelet-rich emboli are associated with von Willebrand factor levels and have poorer revascularization outcomes

  2019cites this paper
• Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research

  2018cites this paper
• The Role of von Willebrand Factor, ADAMTS13, and Cerebral Artery Thrombus Composition in Patient Outcome Following Mechanical Thrombectomy for Acute Ischemic Stroke

  2018cites this paper
• Low dose cadmium upregulates the expression of von Willebrand factor in endothelial cells.

  2018cites this paper
• Relationship between the von Willebrand Factor Plasma Concentration and Ultrasonographic Doppler Findings in Pregnancies Complicated by Hypertensive Disorders: A Pilot Study

  2018cites this paper
• ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia

  2018cites this paper
• of Nursing Ph ton Perceived Impact of Stroke on Quality of Life among Clients in selected Hospitals in Ekiti State , South-West Nigeria

  2018cites this paper
• Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational study

  2018cites this paper
• Endothelial Cell von Willebrand Factor Secretion in Health and Cardiovascular Disease

  2018cites this paper
• Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence

  2018cites this paper
• Effects of anti‐β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity

  2018cites this paper
• Von Willebrand Factor: Multimeric Structure and Functional Activity in Patients With Atrial Fibrillation With and Without Oral Anticoagulation

  2018cites this paper
• Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma

  2018cites this paper
• Role of Endothelial Cells in Acute and Chronic Thrombosis

  2018cites this paper
• The role of von Willebrand factor in determining the risk of ischemic stroke in Hawler city: a case-control study

  2018cites this paper
• CD40L-dependent von Willebrand factor-platelet string formation in the mouse microcirculation in vivo

  2018cites this paper
• A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat

  2017cites this paper
• Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir

  2017cites this paper
• Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage

  2017cites this paper
• Altered preoperative coagulation and fibrinolysis are associated with myocardial injury after non‐cardiac surgery

  2017cites this paper
• New insights into the non-hemostatic role of von Willebrand factor in endothelial protection.

  2017cites this paper
• ADAMTS‐13 and von Willebrand factor: a dynamic duo

  2017cites this paper
• vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology

  2017cites this paper
• From structure to redox: The diverse functional roles of disulfides and implications in disease

  2017cites this paper